Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6017

Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma

$
0
0
Insilico Medicine is having quite a month. Fresh from deals with Servier and Hygtia Therapeutics, the biotech has signed a new collaboration with Shanghai-based Qilu Pharmaceutical worth nearly ...

Viewing all articles
Browse latest Browse all 6017

Trending Articles